Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

oleh: Ana Jiménez-Ubieto, Alejandro Martín-Muñoz, Alejandro Martín-Muñoz, María Poza, Sara Dorado, Sara Dorado, Almudena García-Ortiz, Enrique Revilla, Pilar Sarandeses, Yanira Ruiz-Heredia, Yanira Ruiz-Heredia, Tycho Baumann, Antonia Rodríguez, María Calbacho, Pilar Martínez Sánchez, José María Sánchez Pina, Alejandro Martín García-Sancho, Gloria Figaredo, Laura Rufián, Laura Rufián, Margarita Rodríguez, Margarita Rodríguez, Laura Carneros, Carolina Martínez-Laperche, Mariana Bastos-Oreiro, Chongwu Wang, María-Teresa Cedena, Inmaculada Rapado, Paula de Toledo, Miguel Gallardo, Antonio Valeri, Rosa Ayala, Joaquín Martínez-López, Santiago Barrio, Santiago Barrio

Format: Article
Diterbitkan: Frontiers Media S.A. 2023-08-01

Deskripsi

Subjek

follicular lymphoma; ctDNA (circulating tumor DNA); NGS (Next-Generation Sequencing); minimal residual disease; monitoring; PET/CT 18F-FDG